We then characterized the global expression signature of IL-6+/-/Pax5+/- B-ALLs and compared it with the expression signature of both healthy WT pro-B/pre-B cells and IL-6+/+/Pax5+/- leukemias. This evidence concerns the gene IL6 and leukemia.